The Downside of Right Ventricular Apical Pacing by Brenyo, Andrew et al.
www.ipej.org 102
Review Article 
The Downside of Right Ventricular Apical Pacing
Andrew Brenyo MD, Ilan Goldenberg MD, and Alon Barsheshet MD
Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 
Rochester, NY
Address for Correspondence: Andrew Brenyo MD, University of Rochester Medical Center 
Box 679C, 601 Elmwood Ave, Rochester, NY 14642, USA. E-mail: 
andrew_brenyo/at/urmc.rochester.edu
Abstract
The right ventricular (RV) apex has been the standard pacing site since the development of 
implantable pacemaker technology. Although RV pacing was initially only utilized for the 
treatment of severe bradyarrhythmias usually due to complete heart block, today the indications 
for and implantation of RV pacing devices is dramatically larger.  Recently, the adverse effects 
of chronic RV apical pacing have been described including an increased risk of heart failure 
and death. This review details the detrimental effects of RV apical pacing and their shared 
hemodynamic pathophysiology. In particular, the role of RV apical pacing induced ventricular 
dyssynchrony is highlighted with a specific focus on differential outcome based upon QRS 
morphology at implant.
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Introduction
The development of implantable pacemaker technology in the mid 20th century proved life 
saving for many patients with bradyarrhythmias [1]. In the intervening decades the indications 
for and volumes of permanent pacemaker placement have expanded [2-4] concurrent with a 
geographically dependent aging population. Right ventricular (RV) apical lead placement 
rapidly became standard practice secondary to the ease of site accessibility and lead stability. In 
most situations, RV apical pacing is effective and well tolerated.                                    
However, an increasing amount of data has recently raised questions about the safety of RV 
apical pacing [5-14]. These safety concerns arise from the suggestion that RV apical pacing 
may have detrimental effects on cardiac structure and left ventricular (LV) function [15-17]. 
This is likely the result of the pathologic abnormal electrical and directly related abnormal 
mechanical activation of the ventricles seen as a consequence of RV apical pacing. An 
understanding of this pathophysiology has driven the development of pacing technology to limit 
the need for right ventricular apical pacing and the search for improved methods of ventricular 
pacing.
This review details the detrimental effects of RV apical pacing and its associated hemodynamic 
pathophysiology. In particular, the role of RV apical pacing induced ventricular dyssynchrony 
is highlighted with specific focus on differential outcome based upon QRS morphology at 
implant. Alternative and developing  pacing  strategies  for  patients  with  a  permanent  pacing 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 12 (3): 102-113 (2012)Brenyo A et al, “Downside of Right Ventricular Apical Pacing”                                         103
indication including cardiac resynchronization therapy (CRT), alternative pacing sites, leads, 
programming configurations and energy sources are also discussed.                                          
RV Apical Pacing and Outcome: Clinical Data                                            
For decades, RV apical pacing proved to be an effective therapy for sinus node disease [11], 
atrio-ventricular (AV) block [10], drug-refractory atrial fibrillation [18] and some forms of LV 
dysfunction [19]. A number of randomized studies have focused on the optimal pacing 
configuration and mode dependent on the pacing indication [6,10-14]. In addition to answering 
their intended questions, these studies have also shed light, although often indirectly, on the 
association between RV apical pacing and adverse cardiovascular outcome.                       
Deleterious effects of RV apical pacing: Pacemaker Studies                                  
Studies that have shown the deleterious effects of RV apical pacing can be categorized by the 
indication of pacemaker implantation and by the mode of pacing. Studies enrolling patients 
with sinus node dysfunction compared VVI with AAI pacing or DDD with AAI pacing whereas 
those enrolling patients with AV block compared the effects of DDD with VVI pacing.  
Andersen et al [5] investigated 225 patients with sinus node dysfunction (SND), through a 
comparison of VVI to AAI pacing and found significantly higher cardiovascular mortality, 
incidence of heart failure (HF) and NYHA functional class in the ventricular pacemaker group. 
Several clinical studies [14,20-22] in SND patients displayed that DDD pacing compared to 
AAI pacing induces left atrial dilation and, in the case of a high proportion of RV pacing, also 
reduces LV function, myocardial relaxation and myocardial blood flow. The DANPACE 
(Danish Multicenter Randomized Study on AAI Versus DDD Pacing in SND) study [13-14] 
was designed to prospectively determine if atrial pacing is superior to dual chamber pacing. 
DANPACE randomized 177 patients  with isolated SND (without any significant  atrio-
ventricular conduction disturbance) to one of three pacing modes: AAIR, DDDR with a short 
atrio-ventricular (AV) delay (110–150 ms) and DDDR with a long atrio-ventricular delay (>250 
ms). As expected, there was a significant difference in the frequency of ventricular pacing 
between modes: AAIR (0%), DDDR long AV (17%) and DDDR-short AV (90%). This 
programming dependent increase in frequency of RV pacing was associated with an unadjusted 
increased risk of atrial fibrillation (AF) and stroke. The risk for AF was lowest with atrial 
pacing: AAIR (3% per year), followed by DDDR-long (8.2% per year) and DDDR-short 
(11.7% per year), and there was a trend for fewer thrombo-embolic events with atrial pacing: 
AAIR (1.9% per year), followed by DDDR-long (2.2% per year) and DDDR-short (4.0% per 
year)   [14].                                                                                        
Providing a possible mechanism for the increase in both endpoints, Nielsen et al. demonstrated 
that the use of dual-chamber pacing (i.e. high RV pacing) is associated with left atrial 
enlargement when compared to atrial pacing alone [14]. This suggests that one of the 
deleterious effects of right ventricular pacing may be increased atrial pressure, resulting in 
structural atrial remodeling and increased risk of AF.                                     
Several studies of DDD vs. VVI only pacing in patients with AV block [10] [11], or both AV 
block and SND [12], generated the hypothesis that RV apical pacing may be detrimental (Table 
1). The expectation was that DDD pacing would be beneficial over RV apical only (VVI) 
pacing secondary to maintenance of AV synchrony, resulting in a reduction in heart failure 
(HF), cardiovascular mortality, AF and stroke. Within these studies, only AF was significantly 
reduced with DDD pacing leaving questions regarding the importance of maintaining AV 
synchrony on heart failure and mortality.     
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Table 1: Pacing and ICD studies examining RV pacing and Outcome
      
A subsequent subgroup analysis of MOST (MOde Selection Trial) among patients with QRS 
<120 msec shed light on a possible underlying reason for the negative outcomes of these studies 
[11]. It demonstrated a strong association between RV pacing and the risk of HF events and AF 
in both DDD (mean 90% RV pacing burden, n = 707) and VVI pacing (mean 50% RV pacing 
burden, n = 632) groups. More specifically, patients with greater than 40% of ventricular pacing 
burden in the DDD group and >80% of ventricular pacing in the VVI pacing group had more 
than two fold increased risk for HF events (DDD adjusted hazard ratio (HR): 2.60; 95% 
confidence interval (CI): 1.05 to 6.47; p < 0.05; VVI HR: 2.50; 95% CI: 1.44 to 4.36; p < 0.05). 
Similarly, each 25% increase in RV pacing burden was associated with an approximate mean 
increase of 28% (adjusted 36% for DDD and 21% for VVI only) in AF. The similar increase in 
HF and AF with DDD and VVI only pacing supports the notion that maintenance of AV 
synchrony does not convey a risk reduction in either. Rather, the RV apical pacing burden 
outweighed any benefit of AV synchrony in the DDD group and was the primary driver behind 
the negative trial result. Freudenberger et al, [23] examining more than 11,000 patients who 
underwent pacemaker implantation, found that permanent dual chamber or ventricular pacing in 
patients who did not have HF before implantation, significantly increased their risk for HF 
hospitalizations or HF-related deaths compared with matched control group.                        
Deleterious effects of RV apical pacing: Defibrillator Studies                                   
The DAVID (Dual Chamber and Implantable Defibrillator) trial further substantiated the 
association between RV pacing and adverse cardiovascular outcome [6]. Operating with the 
hypothesis that DDD pacing will convey a reduction in HF, 506 patients with a standard 
indication for ICD implant and no indication for pacing were randomized to "physiologic pacing" 
ICD with DDD backup heart rate 70 (DDD -70) vs. single chamber ICD with VVIR backup heart 
rate 40 (VVI - 40). After one year follow up, the combined endpoint of hospitalization for HF or 
death was significantly higher for the DDD - 70 group (26.7%) compared to the VVI - 40 group 
(16.1%) with an adjusted HR of 1.61 (95% CI 1.06-2.44, p = 0.03). The difference in the backup 
rate between the two groups resulted in a marked difference in the burden of RV pacing with 
DDD - 70 patients paced 60% of the time and VVI - 40 patients just 3% of the time. Congruent 
with findings from MOST, an RV pacing dose dependent positive relationship with adverse 
cardiovascular events was noted.                                                                                       
The MADIT II (Multicenter Automated Defibrillator Implantation Trial II) enrolled 1,232 
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patients with ischemic cardiomyopathy randomized to ICD vs. medical therapy in a 3:2 ratio. 
ICD configurations within the study included single chamber programmed VVI-40 (44%) and 
dual chamber programmed DDD-70 (56%). Steinberg et al reported the short term (median 1.5 
years) follow up of RV pacing in the ICD arm dichotomized by a pacing burden of greater (high 
RV pacing) and less than 50% (low RV pacing) [8]. Patients with high RV pacing were older, 
had higher blood urea nitrogen levels, and were more likely to have wide QRS and LBBB 
compared with non-ICD patients or patients with low RV pacing. After multivariate adjustment, 
high RV pacing patients were at significantly increased risk of new or worsened HF (HR 1.93, p 
= 0.002) and appropriate ICD therapy for VT/VF (HR 1.50, p = 0.02). However, the mortality 
rates were similar for high (13%) and low (10%) RV pacing groups (adjusted HR 1.07, p = 0.78) 
[8].  
Most recently, we have analyzed the association between percent RV pacing and long term 
mortality in MADIT II during an 8-year follow-up [9]. Patients were categorized into three 
subgroups: low RV pacing (< 50% pacing, n = 369), high RV pacing (≥ 50% pacing, n = 198), 
and no ICD (n = 490). During the first 3 years after enrollment, the benefit of the ICD was 
prominent both in patients with low RV pacing (adjusted 65% reduction in risk of death, 
P<0.001) and in those with high RV pacing (adjusted 62% reduction in risk of death, P<0.001); 
In contrast, during the late phase of the extended follow-up period (4-8 years) ICD therapy was 
associated with a significant survival benefit among patients in the low RV pacing subgroup 
(adjusted 40% reduction in mortality risk, P = 0.001) but not in the high RV pacing subgroup 
(adjusted HR = 0.89, P = 0.45). In addition, during the total 8 year follow up, high RV pacing 
was shown to be associated with a significant adjusted 40% (P = 0.01) increase in the risk of 
death compared with low RV pacing (Figure 1). Thus, the long-term benefit of an ICD in 
reducing mortality is prominent in patients with low RV pacing but attenuated in patients with 
high RV pacing, and patients with high versus low RV pacing have increased long term mortality 
risk. A reasonable interpretation of these findings is that frequent RV pacing resulted in 
ventricular dyssynchrony, development and deterioration of HF which takes several years to be 
translated into increased mortality.                                                                                
Figure 1: Probability of long-term mortality by percent of right ventricular pacing and ICD implantation in the 
MADIT II trial with extended follow up. (reproduced with permission of the publisher [9])                         
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The Pathophysiology of RV Apical Pacing                                                                   
The deleterious effects of RV apical pacing have been attributed to the abnormal electrical and 
mechanical activation induced secondary to this form of pacing. During RV apical pacing, the 
electrical wave front propagates through the myocardium, rather than through the His-Purkinje 
conduction system. As a result, the electrical wave front propagates more slowly and induces 
heterogeneity in electrical activation of the myocardium, comparable but not identical to left 
bundle branch block. This is characterized by wave front breakthrough at the interventricular 
septum and latest activation at the infero-posterior base of the left ventricle [24-26].         
Similar to the changes in electrical activation of the ventricles, the mechanical activation pattern 
is altered during RV apical pacing. Importantly, not only does the anatomic onset of mechanical 
contraction differ, but also the resulting pattern of mechanical contraction [27]. Badke et al [28] 
detailed how apical pacing is associated with a diminished rate of change in left ventricular 
pressure (dP/dt) and an abnormal dyssynchronous contraction pattern. The paced region contract 
early at a time of low load, but then is stretched later in systole as the lateral wall finally contracts 
[28-29]. Hemodynamically, asynchronous myocardial contraction significantly decreases the 
stroke volume and right-shifts the left ventricular end-systolic pressure - volume relationship. 
Mismatch between the relaxation of early- and late-contracting regions leads to a decrease in left 
ventricular filling time. Thus, RV apical pacing leads to ventricular dyssynchronization, systolic 
and diastolic ventricular dysfunction, increase in wall stress and energetic inefficiency [29].    
Beyond the hemodynamic effects of ventricular dyssynchrony, it has become clear that long-term 
RV pacing may also result in structural changes and adverse LV remodeling. Originally reported 
in1986 in an RV pacing dog complete heart block model [30], three months of RV pacing 
resulted in myofibrillar disarray in 75% of these dogs. In cardiomyopathies induced by high-rate 
right ventricular apical pacing, they observed significant differences in the expression of proteins 
involved in myocyte contraction, which were  not seen in high-rate  atrial-pacing-induced 
cardiomyopathies with preserved ventricular synchrony [31]. The lateral left ventricular free wall 
(late-activated) displayed the most pronounced cellular derangements, such as down-regulation 
of protein kinases, proteins involved in calcium homeostasis and intercellular connections [31]. 
In addition, changes in LV wall thickness (the early activated wall becomes thinner whereas the 
late activated wall becomes thicker) [17], LV remodeling [32], left atrial remodeling [33], 
functional mitral regurgitation [34], and perfusion abnormalities [35-36] all appear to play a role 
in the pathophysiology of RV apical pacing; predominately as downstream consequences of 
iatrogenic   ventricular   dyssynchrony.                                                                    
RV Pacing and QRS morphology at implant                                                                       
It has long been known that native LBBB can have profound hemodynamic effects due to 
ventricular   dyssynchrony,   particularly   among   patients   with   HF   [37].   As   detailed   above, 
ventricular pacing contributes to the development or exacerbation of HF by producing an 
iatrogenic   form   of   LBBB   and   ventricular   dyssynchrony   reducing   systolic   and   diastolic 
ventricular function. Mechanical activation in patients with chronic RV pacing has been 
compared to those with native LBBB, with patients from both groups having intraventricular 
dyssynchrony, but RV pacing patients displaying greater interventricular dyssynchrony and more 
often had sites of earliest activation from the apex and inferior septum [38].                
We explored the effects of RV pacing on ICD benefit according to LBBB at enrollment in 
MADIT-II during an extended long term follow-up of 8 years [9]. We found that high RV pacing 
was associated with increased long term mortality only in patients who did not have LBBB at 
baseline (Figure 2). Among patients without LBBB, high RV pacing was associated with an 
adjusted 63% (P = 0.002) increase in mortality risk compared with the low RV pacing subgroup, 
whereas among patients with LBBB there was no significant difference in mortality during long-
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term follow-up between high and low RV pacing patients (High vs. low RV pacing adjusted HR 
= 0.74, p=0.343; P value for interaction [QRS morphology by RV pacing burden] = 0.024). 
Consistent with our findings, Saad et al [39] showed in a small study (including 44 HF patients, 
12 with LBBB) that high RV pacing is associated with poor outcome only in the absence of 
LBBB. These findings may suggest that dyssynchrony induced by RV apical pacing is somewhat 
worse than naturally occurring LBBB dyssynchrony. Alternatively, these findings may only 
suggest that RV pacing may not be harmful to patients with systolic HF and LBBB, as the 
incremental dyssynchrony induced by RV pacing is less significant.
Figure 2: Probability of long-term mortality by percent of right ventricular pacing in patients with LBBB (A) and 
without LBBB (B) in the MADIT II trial with extended follow up. (reproduced with permission of the publisher 
[9])
In contrast to these findings, Hayes et al [40] in a substudy of the DAVID trial, found that 
patients programmed to high pacing volume (DDD-70) with an abnormal QRS duration (≥110 
msec) had an unadjusted 25% increased risk of death or hospitalization for HF (p = 0.01). 
Breaking down the abnormal QRS duration group into BBB morphologies, the adverse outcome 
for the group as a whole appeared to be driven by the LBBB patients (30%) that experienced an 
unadjusted 40% increase in HF or death (p = 0.03).                                                    
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Reconciling the stark differences among these studies remains difficult. The primary differences 
between the MADIT-II substudy and the DAVID substudy include different study endpoints 
(death in MADIT II vs. HF or death in DAVID), duration of follow up and indication for pacing. 
DAVID specifically randomized patients based upon pacing programming where the focus of 
MADIT II was the efficacy of primary prevention ICD therapy in ischemic cardiomyopathy. 
Within the MADIT II sub-analysis the primary limitation was the clinical differences between 
high and low RV pacing subgroups. We cannot completely exclude the possibility that sicker 
patients required more pacing and had poorer outcomes as a result. Furthermore, data on percent 
RV pacing were collected only among 79% of the 720 patients who received an ICD in MADIT 
II. Patients who were not included in this data analysis due to missing pacing information 
appeared to be sicker with an elevated in-trial mortality rate of 42% compared with 12% in 
patients analyzed in our study. The DAVID analysis was limited by size and follow up duration. 
Minimizing the Detrimental Effects of RV Pacing                                                        
Methods to avoid the detrimental effects of RV pacing include device programming to minimize 
RV   pacing,   alternative   pacing   sites,   and   biventricular   pacing.   The   current   mainstay   of 
programming based methods to avoid RV pacing includes AV search or MVP (managed 
ventricular pacing) mode. Such programming was evaluated in the SAVE PACe (Search AV 
Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction) trial, 
where 1,065 patients with sinus node disease and intact AV conduction were randomized 
between conventional dual-chamber pacing and dual-chamber minimal ventricular pacing [41]. 
RV pacing burden was significantly reduced with MVP, compared with conventional dual-
chamber ventricular pacing (9.1% vs. 99.0%, p < 0.001). After a mean follow-up of 1.7 years, the 
unadjusted development of persistent atrial fibrillation was significantly reduced with MVP 
(7.9% in minimal RV pacing vs. 12.7% in conventional dual-chamber pacing, p = 0.004). No 
significant   difference   in   HF   or   mortality   was   noted   with   MVP   programming.
When RV pacing is inevitable, the His bundle [42-43], right ventricular outflow tract [44-45] and 
right ventricular septum [46-47] have been studied as alternate pacing sites. Selectively pacing 
these sites may reduce pacing induced ventricular dyssynchrony [48-50] and potentially result in 
a reduction in ventricular volumes with improved LV function compared to RV apical pacing. 
However, with the small size, short term follow up and the absence of a reduction in HF or death 
within the randomized prospective studies, the benefit of alternative site RV pacing remains 
controversial.  
For RV apical pacing dependent patients with abnormal LV function [51-56] or RV apical pacing 
associated HF [57-58], biventricular pacing has emerged as a viable option to minimize the 
detrimental effects of RV pacing. Although some studies have demonstrated a clear long-term 
benefit of CRT over RV pacing with regard to peak VO2 or functional class [51,53], others have 
demonstrated only modest [54-55,57-58] or minimal benefit [56].                             
The PACE trial [59] directly examined the efficacy of biventricular pacing within this population. 
Patients post biventricular pacemakers (177) were prospectively enrolled and randomized to 
receive biventricular pacing (89 patients) or RV apical pacing (88 patients). No significant 
differences in LV ejection fraction (61.5 ± 6.6% for RV pacing, 61.9 ± 6.7 for biventricular 
pacing, p = 0.86) or LV end systolic volume (28.6 ± 10.7ml for RV pacing, 28.6 ± 9.4ml for 
biventricular pacing, p = 0.71) were present at baseline. At 12 months, the mean LV ejection 
fraction was significantly lower in the RV pacing group than in the biventricular-pacing group 
(54.8 ± 9.1% vs. 62.2 ± 7.0%, p < 0.001). Similarly, the LV end-systolic volume was 
significantly higher in the RV pacing group than in the biventricular-pacing group (35.7 ± 16.3 
ml vs. 27.6 ± 10.4 ml, p < 0.001), with a relative change from baseline of 25% (p < 0.001).  
These results support the detrimental effect of RV apical pacing manifest through adverse LV 
remodeling and deterioration in LV function with such effects prevented by biventricular pacing.
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Conclusions
Right ventricular apical pacing is an integral part of the treatment of brady-arrhythmias for the 
majority of patients receiving pacemakers. Right ventricular apical pacing is, however, an often 
pathologic substitute for intrinsic ventricular activation over the His-Purkinje system. Several 
reports indicate that this form of pacing is detrimental potentially increasing the risk of heart 
failure episodes and death, particularly in patients with abnormal LV function. Further studies are 
needed to clarify the mechanisms underlying the deleterious effects of RV pacing, RV apical 
pacing burden to be avoided, and the specific risk factors for poor outcome among patients with 
high RV pacing burden. In the meantime, alternative pacemaker programming and configurations 
are available that can minimize the frequency and detrimental nature of ventricular pacing in 
many pacemaker patients. Additional research will determine if different forms of ventricular 
pacing, such as right ventricular outflow tract, RV septal pacing, or biventricular pacing will 
improve outcomes in patients who require ventricular stimulation.                                         
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